Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operations
HOLX logo

Hologic Revenue Rises 2.5% Amid Segment Shifts and Acquisition Boost

HOLX10-QFiling Date: 1/29/2026
Hologic, Inc.
Description

What this story covers

Hologic's Q1 FY2026 revenue grew 2.5% to $1.048B, driven by GYN Surgical (up 8%) and Skeletal Health surge, offsetting Diagnostics dip. Strong liquidity at $2.2B supports pending Blackstone/TPG merger; recurring revenue buffers volatility in women's health tech.

Story snapshot

CompanyHologic, Inc.
TickerHOLX
VariantStandard detailed
Duration15:08
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000859737-26-000008

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in